Whady Hueb

Summary

Country: Brazil

Publications

  1. doi request reprint Mild chronic kidney dysfunction and treatment strategies for stable coronary artery disease
    Neuza Helena Lopes
    Heart Institute, University of Sao Paulo Medical School, Sao Paulo, Brazil
    J Thorac Cardiovasc Surg 137:1443-9. 2009
  2. ncbi request reprint Hypotheses, rationale, design, and methods for evaluation of ischemic preconditioning assessed by sequential exercise tests in diabetic and non-diabetic patients with stable coronary artery disease--a prospective study
    Paulo Cury Rezende
    Department of Atherosclerosis, Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    BMC Cardiovasc Disord 13:117. 2013
  3. pmc Association between UCP2 A55V polymorphism and risk of cardiovascular events in patients with multi-vessel coronary arterial disease
    Luciana Gioli-Pereira
    Sao Paulo University Medical School, Sao Paulo, Brazil
    BMC Med Genet 14:40. 2013
  4. pmc Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnet
    Whady Hueb
    Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    BMC Cardiovasc Disord 12:65. 2012
  5. pmc Five-year follow-up of angiographic disease progression after medicine, angioplasty, or surgery
    Jorge Chiquie Borges
    Heart Institute InCor, University of São Paulo Medical of School, Sao Paulo, Brazil
    J Cardiothorac Surg 5:91. 2010
  6. doi request reprint Five-year follow-up of a randomized comparison between off-pump and on-pump stable multivessel coronary artery bypass grafting. The MASS III Trial
    Whady Hueb
    Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    Circulation 122:S48-52. 2010
  7. pmc Hypotheses, rationale, design, and methods for prognostic evaluation in type 2 diabetic patients with angiographically normal coronary arteries. The MASS IV-DM Trial
    Whady Hueb
    Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    BMC Cardiovasc Disord 10:47. 2010
  8. ncbi request reprint Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease
    Whady Hueb
    Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    Circulation 115:1082-9. 2007
  9. ncbi request reprint Impact of diabetes on five-year outcomes of patients with multivessel coronary artery disease
    Whady Hueb
    Heart Institute, University of Sao Paulo, Sao Paulo, Brazil
    Ann Thorac Surg 83:93-9. 2007
  10. doi request reprint Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease
    Whady Hueb
    Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    Circulation 122:949-57. 2010

Collaborators

Detail Information

Publications35

  1. doi request reprint Mild chronic kidney dysfunction and treatment strategies for stable coronary artery disease
    Neuza Helena Lopes
    Heart Institute, University of Sao Paulo Medical School, Sao Paulo, Brazil
    J Thorac Cardiovasc Surg 137:1443-9. 2009
    ....
  2. ncbi request reprint Hypotheses, rationale, design, and methods for evaluation of ischemic preconditioning assessed by sequential exercise tests in diabetic and non-diabetic patients with stable coronary artery disease--a prospective study
    Paulo Cury Rezende
    Department of Atherosclerosis, Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    BMC Cardiovasc Disord 13:117. 2013
    ..However, it is still unknown whether diabetes may influence the expression of ischemic preconditioning in patients with stable multivessel coronary artery disease...
  3. pmc Association between UCP2 A55V polymorphism and risk of cardiovascular events in patients with multi-vessel coronary arterial disease
    Luciana Gioli-Pereira
    Sao Paulo University Medical School, Sao Paulo, Brazil
    BMC Med Genet 14:40. 2013
    ....
  4. pmc Hypotheses, rationale, design, and methods for prognostic evaluation of cardiac biomarker elevation after percutaneous and surgical revascularization in the absence of manifest myocardial infarction. A comparative analysis of biomarkers and cardiac magnet
    Whady Hueb
    Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    BMC Cardiovasc Disord 12:65. 2012
    ....
  5. pmc Five-year follow-up of angiographic disease progression after medicine, angioplasty, or surgery
    Jorge Chiquie Borges
    Heart Institute InCor, University of São Paulo Medical of School, Sao Paulo, Brazil
    J Cardiothorac Surg 5:91. 2010
    ..This study compared progression of coronary artery disease in native coronary arteries in patients undergoing surgery, angioplasty, or medical treatment...
  6. doi request reprint Five-year follow-up of a randomized comparison between off-pump and on-pump stable multivessel coronary artery bypass grafting. The MASS III Trial
    Whady Hueb
    Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    Circulation 122:S48-52. 2010
    ..Few data are available on the effects of off-pump coronary artery bypass graft surgery (OPCAB) on cardiac events and long-term clinical outcomes...
  7. pmc Hypotheses, rationale, design, and methods for prognostic evaluation in type 2 diabetic patients with angiographically normal coronary arteries. The MASS IV-DM Trial
    Whady Hueb
    Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    BMC Cardiovasc Disord 10:47. 2010
    ..The MASS IV-DM Trial is a large project from a single institution, the Heart Institute (InCor), University of São Paulo Medical School, Brazil to study ventricular function and coronary arteries in patients with type 2 diabetes mellitus...
  8. ncbi request reprint Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease
    Whady Hueb
    Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    Circulation 115:1082-9. 2007
    ....
  9. ncbi request reprint Impact of diabetes on five-year outcomes of patients with multivessel coronary artery disease
    Whady Hueb
    Heart Institute, University of Sao Paulo, Sao Paulo, Brazil
    Ann Thorac Surg 83:93-9. 2007
    ....
  10. doi request reprint Ten-year follow-up survival of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease
    Whady Hueb
    Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    Circulation 122:949-57. 2010
    ....
  11. ncbi request reprint The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results
    Whady Hueb
    Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    J Am Coll Cardiol 43:1743-51. 2004
    ..We sought to evaluate the relative efficacies of three possible therapeutic strategies for patients with multivessel coronary artery disease (CAD), stable angina, and preserved ventricular function...
  12. ncbi request reprint Effect of complete revascularization on 10-year survival of patients with stable multivessel coronary artery disease: MASS II trial
    Ricardo D Oliveira Vieira
    Department of Atherosclerosis, Heart Institute of University of São Paulo, Sao Paulo, Brazil
    Circulation 126:S158-63. 2012
    ....
  13. ncbi request reprint Long-term analysis of left ventricular ejection fraction in patients with stable multivessel coronary disease undergoing medicine, angioplasty or surgery: 10-year follow-up of the MASS II trial
    Cibele Larrosa Garzillo
    Department of Atherosclerosis, Heart Institute of the University of Sao Paulo, Av Dr Eneas de Carvalho Aguiar 44, AB, Sala 114, Cerqueira Cesar, São Paulo SP 05403 000, Brazil
    Eur Heart J 34:3370-7. 2013
    ..Thus, we evaluated the evolution of LV ejection fraction (LVEF) in patients with stable coronary artery disease (CAD) treated by CABG, PCI, or MT as a post hoc analysis of a randomized controlled trial with a follow-up of 10 years...
  14. ncbi request reprint Clinical judgment and treatment options in stable multivessel coronary artery disease: results from the one-year follow-up of the MASS II (Medicine, Angioplasty, or Surgery Study II)
    Alexandre C Pereira
    Heart Institute InCor, University of Sao Paulo Medical School, Sao Paulo, Brazil
    J Am Coll Cardiol 48:948-53. 2006
    ....
  15. ncbi request reprint Cost-effectiveness analysis for surgical, angioplasty, or medical therapeutics for coronary artery disease: 5-year follow-up of medicine, angioplasty, or surgery study (MASS) II trial
    Ricardo D Oliveira Vieira
    Department of Atherosclerosis, Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    Circulation 126:S145-50. 2012
    ..This investigation compares the economic outcome at 5-year follow-up of the 3 therapeutic strategies...
  16. doi request reprint Impact of diabetes on 10-year outcomes of patients with multivessel coronary artery disease in the Medicine, Angioplasty, or Surgery Study II (MASS II) trial
    Eduardo Gomes Lima
    Department of Atherosclerosis, Heart Institute InCor Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil
    Am Heart J 166:250-7. 2013
    ..Our aim was to compare 3 therapeutic strategies for stable multivessel CAD in a diabetic population and non-diabetic population...
  17. ncbi request reprint Effect of a hypoglycemic agent on ischemic preconditioning in patients with type 2 diabetes and stable angina pectoris
    Whady Hueb
    Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    Coron Artery Dis 18:55-9. 2007
    ....
  18. pmc Effect of hypoglycemic agents on ischemic preconditioning in patients with type 2 diabetes and symptomatic coronary artery disease
    Rosa Maria Rahmi
    Department of Atherosclerosis, Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    Diabetes Care 36:1654-9. 2013
    ..To assess the effect of two hypoglycemic drugs on ischemic preconditioning (IPC) patients with type 2 diabetes and coronary artery disease (CAD)...
  19. doi request reprint Cancer-related deaths among different treatment options in chronic coronary artery disease: results of a 6-year follow-up of the MASS II study
    Ricardo D Vieira
    Heart Institute InCor of the University of Sao Paulo, Sao Paulo, Brazil
    Coron Artery Dis 23:79-84. 2012
    ..Noncardiac causes of death may distort the interpretation of the long-term effects of coronary revascularization...
  20. ncbi request reprint Dynamic regulation of MTHFR mRNA expression and C677T genotype modulate mortality in coronary artery disease patients after revascularization
    Alexandre C Pereira
    Heart Institute, University of Sao Paulo Medical School, Sao Paulo, Brazil
    Thromb Res 121:25-32. 2007
    ..Here, we investigate whether MTHFR gene variants are associated with an increased cardiovascular risk in individuals submitted to CABG. We also propose a molecular mechanism to explain our findings...
  21. doi request reprint Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: effect of age in the Medicine, Angioplasty, or Surgery Study II trial
    Paulo Cury Rezende
    Department of Atherosclerosis, Heart Institute of the University of Sao Paulo, Sao Paulo, Brazil
    J Thorac Cardiovasc Surg 146:1105-12. 2013
    ..The current study compared the 3 treatment options for coronary artery disease in patients aged 65 years or more and analyzed the impact of age in treatment options...
  22. doi request reprint Impact of metabolic syndrome on the outcome of patients with stable coronary artery disease: 2-year follow-up of the MASS II study
    Neuza H Lopes
    Heart Institute InCor of the University of Sao Paulo, Sao Paulo, Brazil
    Coron Artery Dis 19:383-8. 2008
    ..We characterized the impact of the metabolic syndrome (MetS) and its components on cardiovascular adverse events in patients with symptomatic chronic multivessel coronary artery disease, which have been followed prospectively for 2 years...
  23. ncbi request reprint Effect of glycoprotein IIIa PlA2 polymorphism on outcome of patients with stable coronary artery disease and effect of smoking
    Neuza H M Lopes
    Heart Institute InCor of the University of Sao Paulo, Sao Paulo, Brazil
    Am J Cardiol 93:1469-72. 2004
    ..Smokers with the Pl(A2) polymorphism of platelet glycoprotein IIIa are at greater risk for subsequent cardiac events in stable coronary disease...
  24. ncbi request reprint The effects of glibenclamide, a K(ATP) channel blocker, on the warm-up phenomenon
    Beatriz M A Ferreira
    Heart Institute of the University of Sao Paulo, Brazil
    Ann Noninvasive Electrocardiol 10:356-62. 2005
    ..This study aimed to investigate the effects of chronic treatment with glibenclamide during two sequential exercise tests...
  25. doi request reprint Hemostatic changes and clinical sequelae after on-pump compared with off-pump coronary artery bypass surgery: a prospective randomized study
    Felipe S Paulitsch
    Heart Institute, University of Sao Paulo, Sao Paulo, Brazil
    Coron Artery Dis 20:100-5. 2009
    ..To delineate the effects of extracorporeal bypass on biomarkers of hemostasis, fibrinolysis, and inflammation and clinical sequelae...
  26. ncbi request reprint Quality of life in patients with symptomatic multivessel coronary artery disease: a comparative post hoc analyses of medical, angioplasty or surgical strategies-MASS II trial
    Maria Elenita Favarato
    Heart Institute InCor, University of Sao Paulo School of Medicine, Sao Paulo, SP, Brazil
    Int J Cardiol 116:364-70. 2007
    ..We evaluated the impact of Coronary Artery Bypass Graft Surgery (CABG), Percutaneous Coronary Intervention (PCI) or Medical Therapy (MT) on self-perceived quality of life among patients with stable Coronary Artery Disease (CAD)...
  27. ncbi request reprint Quality of life after surgical myocardial revascularization, angioplasty or medical treatment
    Myrthes Emy Takiuti
    Instituto do Coracao, Hospital das Clinicas, FM, USP, Sao Paulo, SP, Brazil
    Arq Bras Cardiol 88:537-44. 2007
    ..Although the clinical benefits of coronary interventions seem to be confirmed, their effects on quality of life (QoL) are still scarcely studied...
  28. ncbi request reprint Plasma kinetics of a cholesterol-rich emulsion in subjects with or without coronary artery disease
    Raul D Santos
    Lipid Metabolism Laboratory, The Heart Institute InCor, Medical School Hospital InCor HCFMUSP, University of Sao Paulo, Sao Paulo, Brazil
    J Lipid Res 44:464-9. 2003
    ..In conclusion, both removal from the plasma and esterification of the LDE-cholesterol were increased in CAD. These findings may contribute for unraveling pro-atherogenic mechanisms and the establishment of novel CAD markers...
  29. ncbi request reprint Effects of epinephrine in local dental anesthesia in patients with coronary artery disease
    Ricardo Simões Neves
    Instituto do Coracao, Hospital das Clinicas, FM, USPSão Paulo, SP, Brazil
    Arq Bras Cardiol 88:545-51. 2007
    ..The use of vasoconstrictors for local anesthesia in patients with coronary heart disease is controversial in the literature, and there is concern regarding risk of cardiac decompensation...
  30. pmc Teratoma of the mediastinum: a case report
    Ricardo D Vieira
    Department of Atherosclerosis, Heart Institute of the University of Sao Paulo, Av Dr Eneas de Carvalho Aguiar 44, AB, Sala 114, Cerqueira Cesar, Sao Paulo SP, 05403 000, Brazil
    J Med Case Reports 5:193. 2011
    ..abstract:..
  31. ncbi request reprint Relative cost comparison of treatments for coronary artery disease: the First Year Follow-Up of MASS II Study
    Desiderio Favarato
    Heart Institute InCor, University of Sao Paulo School of Medicine, Sao Paulo SP, Brazil
    Circulation 108:II21-3. 2003
    ..The MASS II trial provides an opportunity to compare the costs of CABG and PTCA in addition to a strategy of medical therapy...
  32. ncbi request reprint Acute pleuropulmonary complications detected by computed tomography following myocardial revascularization
    Francisco S Vargas
    Heart Institute, Hospital das Clinicas, Faculty of Medicine, University of Sao Paulo, Brazil
    Rev Hosp Clin Fac Med Sao Paulo 57:135-42. 2002
    ..The presence of atelectasis or pleural effusions reflects the thoracic trauma...
  33. ncbi request reprint LDL concentration is correlated with the removal from the plasma of a chylomicron-like emulsion in subjects with coronary artery disease
    Andrei C Sposito
    Heart Institute InCor, University of Sao Paulo Medical School, Sao Paulo, Brazil
    Atherosclerosis 161:447-53. 2002
    ..Concluding, in patients with CAD, LDL catabolic pathway significantly influences the removal from plasma of chylomicron remnants...
  34. ncbi request reprint Impaired intravascular triglyceride lipolysis constitutes a marker of clinical outcome in patients with stable angina undergoing secondary prevention treatment: a long-term follow-up study
    Andrei C Sposito
    Heart Institute InCor, Zerbini Foundation, Brasilia, Brazil
    J Am Coll Cardiol 43:2225-32. 2004
    ..We sought to verify whether the intravascular metabolism of chylomicron-like emulsion may predict the clinical evolution of patients with coronary artery disease (CAD) undergoing secondary prevention therapy of CAD...